Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus Glimepiride

Clinical trial NCT01233622 · COMPLETED

Trial details

NCT number: NCT01233622
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2010-10-01
Primary completion: 2011-11-01
Enrollment: 317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.